title: Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
authors.forename: M
authors.initials: M
authors.lastname: Economou
authors.forename: A
authors.initials: A
authors.lastname: Teli
authors.forename: A
authors.initials: A
authors.lastname: Tzantzaroudi
authors.forename: I
authors.initials: I
authors.lastname: Tsatra
authors.forename: A
authors.initials: A
authors.lastname: Zavitsanakis
authors.forename: M
authors.initials: M
authors.lastname: Athanassiou-Metaxa
mesh_terms: D000293:Adolescent; D001062:Appendectomy; D001323:Autoantibodies / Q000097:blood; D001779:Blood Coagulation Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000276:immunology; D015942:Factor VIIa / Q000008:administration & dosage* / Q000627:therapeutic use; D006467:Hemophilia A / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D001323:Autoantibodies; D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; D005169:Factor VIII; C103587:recombinant FVIIa; C065655:anti-inhibitor coagulant complex; D015942:Factor VIIa